A Multi Center Study of Sexual Toxicities After Radiotherapy

Part of paid clinical trials in Atlanta, Georgia.

Sponsor
Icahn School of Medicine at Mount Sinai
Study ID
NCT05394428
Status
Recruiting

Conditions

  • Malignant Neoplasms

Eligibility Criteria

Sex
FEMALE
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • No intervention — OTHER
    No intervention

Study Details

The purpose of this research is to understand how radiotherapy and other cancer treatments impact sexual function in female cancer patients and to try to answer a question about why some patients who receive radiotherapy are more likely to have side effects than others. The results of this study may improve our understanding of why sexual side effects occur and in turn develop predictive models and biomarkers of sexual side effects and other side effects that may impact sexual function. The results of this study may also lead to improvements in the techniques used to deliver radiotherapy or the development of interventions that will prevent or reduce sexual side effects and improve quality of life for female patients with cancer.

Key Dates

Start date
Oct 4, 2022
Status verified
Nov 2024
Primary completion
Aug 31, 2026
Completion
Aug 31, 2026

Study Design

Enrollment
300 participants (estimated)

Arms

  • Arm: Patients with female sexual organs treated with pelvic radiotherapy
    Patients with female sexual organs treated with pelvic radiotherapy.

Primary Outcome Measure

Establish Sexual Quality of Life Cohort [ Time Frame: 2 years ]

Central Contacts

Locations (3)

FacilityCityStateZIPSite coordinators
Emory UniversityAtlantaGeorgia30322
Mylin Torres, MD, BA (PRINCIPAL_INVESTIGATOR)
Icahn School of Medicine at Mount SinaiNew YorkNew York10029
Deborah C Marshall, MD
Natasha A Gironimi
Deborah C Marshall, MD (PRINCIPAL_INVESTIGATOR)
M.D. Anderson Cancer CenterHoustonTexas77030
Anuja Jhingran, MD (PRINCIPAL_INVESTIGATOR)

Find similar trials in Atlanta, GA

Related Studies